UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the Child‐Pugh score

Alimentary Pharmacology & Therapeutics (Suppl), 2011-11, Vol.34 (10), p.1193-1201

2011

Volltextzugriff (PDF)

Modulation of functional connectivity following visual adaptation: Homeostasis in V1

Brain research, 2015-01, Vol.1594, p.136-153

2015

Volltextzugriff (PDF)

Synergistic activity between primary visual neurons

Neuroscience, 2014-05, Vol.268, p.255-264

2014

Volltextzugriff (PDF)

Outcomes by baseline alpha-fetoprotein (AFP) levels in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in previously treated advanced hepatocellular carcinoma (HCC)

Annals of oncology, 2018-10, Vol.29, p.viii236-viii236

2018

Volltextzugriff (PDF)

Eclipsed mitral regurgitation: an unusual cause of acute heart failure

European heart journal cardiovascular imaging, 2017-10, Vol.18 (10), p.1163-1169

2017

Volltextzugriff (PDF)

Crohn's disease clinical course and severity in obese patients

Clinical nutrition (Edinburgh, Scotland), 2002-02, Vol.21 (1), p.51-57

2002

Volltextzugriff (PDF)

Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome

Diabetes & metabolism, 2012-04, Vol.38 (2), p.113-127

2012

Volltextzugriff (PDF)

Oc026—Impact Of Circulating Levels Of Interleukin-17 And Cardiovascular Outcomes In Patients With Acute Myocardial Infarction

Clinical therapeutics, 2013-08, Vol.35 (8), p.e11-e11

2013

Volltextzugriff (PDF)

Effects of current and former cigarette smoking on the clinical course of Crohn’s disease

Alimentary pharmacology & therapeutics, 1999-11, Vol.13 (11), p.1403-1411

1999

Volltextzugriff (PDF)

Reduction of radiation exposure associated with renewal of the radiologic systems in coronary interventions

Annales de cardiologie et d'angeiologie, 2018-11, Vol.67 (5), p.334-338

2018

Volltextzugriff (PDF)

661 ULTRASONOGRAPHIC (US) SCREENING OF HEPATOCELLULAR CARCINOMA (HCC) IN COMPENSATED CIRRHOSIS DUE TO HEPATITIS C VIRUS (HCV) IMPROVES SURVIVAL: A MODELING APPROACH

Journal of hepatology, 2013-04, Vol.58, p.S269-S269

2013

Volltextzugriff (PDF)

Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis

Alimentary pharmacology & therapeutics, 2000-03, Vol.14 (3), p.273-279

2000

Volltextzugriff (PDF)

P30 Prendre en considération le sexe masculin et la présence d’une rétinopathie diabétique avec les critères ALFEDIAM-SFC 2004 permet de dépister plus efficacement la maladie coronaire silencieuse chez les diabétiques de type 2

Diabetes & metabolism, 2012-03, Vol.38, p.A39-A39

2012

Volltextzugriff (PDF)

P50 Le pronostic des diabétiques de type 2 avec sténoses coronaires silencieuses est amélioré par la revascularisation

Diabetes & metabolism, 2012-03, Vol.38, p.A43-A43

2012

Volltextzugriff (PDF)

Diagnostic value of cardiac magnetic resonance in patients presenting with chest pain, troponin elevation and unobstructed coronary arteries

Archives of cardiovascular diseases, 2013-04, Vol.106 (4), p.244-244

2013

Volltextzugriff (PDF)

Detecting silent coronary stenoses and stratifying cardiac risk in patients with diabetes: ECG stress test or exercise myocardial scintigraphy?

Diabetic medicine, 2004-04, Vol.21 (4), p.342-348

2004

Volltextzugriff (PDF)

626 ASSESSMENT OF RESPONSE TO SORAFENIB IN HEPATOCELLULAR CARCINOMA: PROGNOSTIC VALUE OF TUMORAL DENSITY AND ARTERIAL ENHANCEMENT MEASUREMENTS IN TARGET LESIONS

Journal of hepatology, 2011-03, Vol.54, p.S254-S254

2011

Volltextzugriff (PDF)

Hybrid Mobilities: Transgressive Spatialities

1, 2022

Volltextzugriff (PDF)

Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial

Clinical cancer research, 2022-06, Vol.28 (12), p.2547-2554

2022

Volltextzugriff (PDF)

O4 Intérêt de la revascularisation de la maladie coronaire silencieuse chez le diabétique : une étude rétrospective

Diabetes & metabolism, 2010, Vol.36, p.A1-A2

2010

Volltextzugriff (PDF)

P48 Dysglycémie méconnue et risque de diabète chez les coronariens

Diabetes & metabolism, 2010, Vol.36, p.A51-A51

2010

Volltextzugriff (PDF)

Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome

Archives of cardiovascular diseases, 2012-04, Vol.105 (4), p.239-253

2012

Volltextzugriff (PDF)

Long‐term evolution of disease behavior of Crohn's disease

Inflammatory bowel diseases, 2002-07, Vol.8 (4), p.244-250

2002

Volltextzugriff (PDF)

66 PROSPECTIVE EVALUATION OF SORAFENIB (SO) IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): DOES CHILD SCORE B INFLUENCE SAFETY?

Journal of hepatology, 2009-04, Vol.50, p.S28-S28

2009

Volltextzugriff (PDF)

Pembrolizumab (pembro) in patients (pts) with sorafenib-treated (cohort 1) and treatment (tx)-naive (cohort 2) advanced hepatocellular carcinoma (aHCC) after additional follow-up in the phase 2 KEYNOTE-224 study

Journal of clinical oncology, 2024, Vol.42 (16_suppl), p.4100-4100

2024

Volltextzugriff (PDF)

1 – 25 von 2.027

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.191)
Mit Volltextzugriff
(1.295)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the Child‐Pugh score

Modulation of functional connectivity following visual adaptation: Homeostasis in V1

Synergistic activity between primary visual neurons

Outcomes by baseline alpha-fetoprotein (AFP) levels in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in previously treated advanced hepatocellular carcinoma (HCC)

Eclipsed mitral regurgitation: an unusual cause of acute heart failure

Crohn's disease clinical course and severity in obese patients

Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome

Oc026—Impact Of Circulating Levels Of Interleukin-17 And Cardiovascular Outcomes In Patients With Acute Myocardial Infarction

Effects of current and former cigarette smoking on the clinical course of Crohn’s disease

Reduction of radiation exposure associated with renewal of the radiologic systems in coronary interventions

661 ULTRASONOGRAPHIC (US) SCREENING OF HEPATOCELLULAR CARCINOMA (HCC) IN COMPENSATED CIRRHOSIS DUE TO HEPATITIS C VIRUS (HCV) IMPROVES SURVIVAL: A MODELING APPROACH

Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis

P30 Prendre en considération le sexe masculin et la présence d’une rétinopathie diabétique avec les critères ALFEDIAM-SFC 2004 permet de dépister plus efficacement la maladie coronaire silencieuse chez les diabétiques de type 2

P50 Le pronostic des diabétiques de type 2 avec sténoses coronaires silencieuses est amélioré par la revascularisation

Diagnostic value of cardiac magnetic resonance in patients presenting with chest pain, troponin elevation and unobstructed coronary arteries

Detecting silent coronary stenoses and stratifying cardiac risk in patients with diabetes: ECG stress test or exercise myocardial scintigraphy?

626 ASSESSMENT OF RESPONSE TO SORAFENIB IN HEPATOCELLULAR CARCINOMA: PROGNOSTIC VALUE OF TUMORAL DENSITY AND ARTERIAL ENHANCEMENT MEASUREMENTS IN TARGET LESIONS

Hybrid Mobilities: Transgressive Spatialities

Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial

O4 Intérêt de la revascularisation de la maladie coronaire silencieuse chez le diabétique : une étude rétrospective

P48 Dysglycémie méconnue et risque de diabète chez les coronariens

Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome

Long‐term evolution of disease behavior of Crohn's disease

66 PROSPECTIVE EVALUATION OF SORAFENIB (SO) IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): DOES CHILD SCORE B INFLUENCE SAFETY?

Pembrolizumab (pembro) in patients (pts) with sorafenib-treated (cohort 1) and treatment (tx)-naive (cohort 2) advanced hepatocellular carcinoma (aHCC) after additional follow-up in the phase 2 KEYNOTE-224 study

Suchergebnisse filtern